Ignite Creation Date:
2025-12-25 @ 12:01 AM
Ignite Modification Date:
2025-12-30 @ 8:05 PM
Study NCT ID:
NCT00936858
Status:
COMPLETED
Last Update Posted:
2021-10-22
First Post:
2009-07-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
RAD001 for Patients With Radioiodine Refractory Thyroid Cancer
Sponsor:
Dana-Farber Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-07
Start Date Type:
ACTUAL
Primary Completion Date:
2020-02-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-02-27
Completion Date Type:
ACTUAL
First Submit Date:
2009-07-09
First Submit QC Date:
None
Study First Post Date:
2009-07-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-09-01
Results First Submit QC Date:
None
Results First Post Date:
2021-09-28
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-10-01
Last Update Post Date:
2021-10-22
Last Update Post Date Type:
ACTUAL